Forward Science donates OralID to NC Missions of Mercy
July 29, 2014 -- Forward Science Technologies, the developer of OralID and CytID, recently awarded an OralID device to North Carolina Missions of Mercy (NCMOM).
Antipain agent shrinks oral cancers without damaging healthy tissue
July 25, 2014 -- Mouse models of human oral cancer treated with capsazepine showed dramatic tumor shrinkage without damage to surrounding tissues, according to a study in Oral Oncology. Capsazepine's anticancer effects may stem from its ability to increase oxidative damage in tumors, Texas researchers said.
CEL-SCI expands head/neck cancer drug trial
July 25, 2014 -- CEL-SCI is expanding the phase III clinical trial of its investigational cancer immunotherapy therapy, Multikine, to the U.K., Austria, Turkey, and Sri Lanka. The company hopes to enroll 880 patients in 20 countries by the end of 2015.
Zilico gets funding to develop device to detect oral cancer
July 25, 2014 -- Medical products developer Zilico has secured funding to develop a new device that detects oral cancer.
CDC study: HPV vaccines could prevent most oropharyngeal cancers
July 23, 2014 -- Human papillomavirus (HPV) vaccines could prevent most oropharyngeal cancers in the U.S., according to a new Centers for Disease Control and Prevention (CDC) study in Emerging Infectious Diseases. The analysis of patients with oropharyngeal cancer found that most were HPV-positive, especially for HPV types 16 and 18, and the majority of patients were white men.
Advaxis, MedImmune partner on clinical trial
July 22, 2014 -- Advaxis, a biotechnology company that develops cancer immunotherapies, has entered a clinical trial collaboration with MedImmune, the biologics research and development arm of AstraZeneca.
LSU researcher gets grant to develop cancer-preventing gum
July 18, 2014 -- A Louisiana State University (LSU) researcher has received a $50,000 grant to produce a potentially cancer-preventing gum that uses curcumin, a substance found in the spice turmeric.
Oral Cancer Foundation, Cody Kiser partner for Idaho rodeo
July 17, 2014 -- The Oral Cancer Foundation is partnering with Cody Kiser, a rodeo cowboy who will serve as a spokesman for the group, at the Snake River Stampede Rodeo, held July 15-19 in Nampa, ID.
Investigational drug may benefit head/neck cancer patients
July 14, 2014 -- The investigational drug dacomitinib may benefit patients with recurrent or metastatic squamous cell carcinoma of the head and neck, according to the results of phase II clinical trial by researchers in South Korea.
ACS awards $1.7M to study racial disparities in HNC patients
July 10, 2014 -- The American Cancer Society (ACS) has awarded a $1.7 million grant to Philadelphia researchers to investigate factors that may contribute to the racial disparities seen among those diagnosed and treated for head and neck cancers (HNC).
Special Feature
Aspirin can help battle head/neck cancer

Aspirin appears to offer significant protection against head and neck (HNC) cancer, according to a study in the British Journal of Cancer. Regular aspirin use was associated with a 22% reduction in HNC and seems to be particularly effective in preventing laryngeal cancer. Read more.

Vendor Connect
Dentifrices and Consumer Products
Dry Mouth Products
Tools and Instruments
Oral Cancer Detection

|| Advertising || Building Your Practice || Case Archives || Case Study || Topics || Conferences || Contact Us || Education || Facebook || Forums || Home || Jobs || Links || Mobile || News in Brief || Online CE || Thought Leaders || Privacy Policy || Twitter || Vendor Connect || XML/RSS ||

Copyright © 2014 All Rights Reserved.